Circular economy towards the future
Boehringer Ingelheim uses eco-design to shape and develop animal health products with an improved environmental profile. Click here to read more.
Search
Cat care interview veterinarian Dr Susan Little
We interviewed world-renowned feline healthcare specialist Dr Susan Little to get her thoughts on cat care. Click here to read and find out more.
Marek's Disease Poultry Chicken
Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems. Learn more here.
pet care digital age
Pets can be family members, trusted companions – and they are also part of a large global industry. Learn more about pet care in the digital age here.
COVID-19 Making More Health support program
Find out what our communities, local partners and social entrepreneurs in the Making More Health network do. Click here to find out and learn more.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
Dortmund
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Dortmund site.
Our Approach
As a family-owned company, we are driven by the ambition to serve humankind by improving human and animal health. Find out more about our approach here.
Boehringer Ingelheim China for a green future
Together with all other functions, Fangya Qiang oversees the MORE GREEN programme at Boehringer Ingelheim’s Chinese locations. Click here to learn more.
COVID-19 Mexico - The value of teamwork
During the pandemic, Fabiola Villegas, contributed with creativity and ingenuity from her region in Uruapan, Michoacán, Mexico. Click here to learn more.
How pets made the pandemic bearable?
Lockdown wasn’t easy but having us work from home was certainly delightful for our pets. Learn some insights from the APPA COVID-19 Pulse Study.
New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. Read more.
1885-1948
In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. Click here to learn more about our history.
COVID-19 Collaboration with Cantaro Azul in Mexico
Boehringer Ingelheim Mexico is collaborating with the NGO Cántaro Azul to provide hand sanitisers to people without access to clean water. Learn more here.
Back to life
Anna Higgs had a severe stroke at the age of 24. For years she has been struggling with the consequences. Click here to learn more about her story.
NexGard Spectra launched in China
Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.
Supporting Fundappas
Fundappas is the first school of guide and assistance dogs in Uruguay. We support Fundappas to improve the quality of life of dogs and people. Learn more.
COVID-19 Volunteering in Mexico
Sonia Angulo, Medical Representative of Human Pharma in Mexico, has become a hero for many health workers who are facing the COVID-19 pandemic. Learn more.
Development Biotechnology sustainable cell culture
Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint.
fighting pet parasites with holistic approach france
When animals are healthy, humans are healthier, too. This is especially true for parasitic diseases that affect our pets to whom we are close. Read more.
Boehringer Ingelheim announces appointment of Vani Manja as India Country MD
Boehringer Ingelheim has announced that Vani Manja is appointed Country Managing Director for India. Read the press release here and find out more.
It is about saving lives Alexis Jaliquias feline blood bank
Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America. Click here to read about this story and find out more.
More health in vulnerable communities
Making More Health, offers expertise, network and financial support to social entrepreneurs, plus more. Read more about Making More Health here.
1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India. Click here to find out and learn more.